227 related articles for article (PubMed ID: 31494989)
1. Lymphomatoid papulosis: an update and review.
Martinez-Cabriales SA; Walsh S; Sade S; Shear NH
J Eur Acad Dermatol Venereol; 2020 Jan; 34(1):59-73. PubMed ID: 31494989
[TBL] [Abstract][Full Text] [Related]
2. CD30-Positive Lymphoproliferative Disorders.
Nikolaenko L; Zain J; Rosen ST; Querfeld C
Cancer Treat Res; 2019; 176():249-268. PubMed ID: 30596222
[TBL] [Abstract][Full Text] [Related]
3. Localized lymphomatoid papulosis: Unilesional lymphomatoid papulosis, regional lymphomatoid papulosis, and persistent agmination of lymphomatoid papulosis.
Magro CM; Mo JH; Telang G
Clin Dermatol; 2022; 40(6):622-638. PubMed ID: 35907581
[TBL] [Abstract][Full Text] [Related]
4. A new era for cutaneous CD30-positive T-cell lymphoproliferative disorders.
Kempf W
Semin Diagn Pathol; 2017 Jan; 34(1):22-35. PubMed ID: 27993440
[TBL] [Abstract][Full Text] [Related]
5. CD30
Sauder MB; O'Malley JT; LeBoeuf NR
Hematol Oncol Clin North Am; 2017 Apr; 31(2):317-334. PubMed ID: 28340881
[TBL] [Abstract][Full Text] [Related]
6. Primary Cutaneous CD30+ Lymphoproliferative Disorders: a Comprehensive Review.
Di Raimondo C; Parekh V; Song JY; Rosen ST; Querfeld C; Zain J; Martinez XU; Abdulla FR
Curr Hematol Malig Rep; 2020 Aug; 15(4):333-342. PubMed ID: 32435988
[TBL] [Abstract][Full Text] [Related]
7. Histopathological aspects and differential diagnosis of CD8 positive lymphomatoid papulosis.
Marschalkó M; Gyöngyösi N; Noll J; Károlyi Z; Wikonkál N; Hársing J; Kuroli E; Csomor J; Matolcsy A; Sarolta K; Szepesi Á
J Cutan Pathol; 2016 Nov; 43(11):963-973. PubMed ID: 27461449
[TBL] [Abstract][Full Text] [Related]
8. Primary cutaneous CD30(+) lymphoproliferative disorders.
Wieser I; Tetzlaff MT; Torres Cabala CA; Duvic M
J Dtsch Dermatol Ges; 2016 Aug; 14(8):767-82. PubMed ID: 27509411
[TBL] [Abstract][Full Text] [Related]
9. MUM1 expression in cutaneous CD30+ lymphoproliferative disorders: a valuable tool for the distinction between lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.
Kempf W; Kutzner H; Cozzio A; Sander CA; Pfaltz MC; Müller B; Pfaltz M
Br J Dermatol; 2008 Jun; 158(6):1280-7. PubMed ID: 18410414
[TBL] [Abstract][Full Text] [Related]
10. CD8-positive lymphomatoid papulosis (type D): Some lesions may lack CD30 expression and overlap histologically with mycosis fungoides.
Simo OC; Warren SJ; Mark L; Hoffmann K; Alomari AK
Int J Dermatol; 2019 Jul; 58(7):800-805. PubMed ID: 30520526
[TBL] [Abstract][Full Text] [Related]
11. CD30+ cutaneous lymphoproliferative disorders: the Stanford experience in lymphomatoid papulosis and primary cutaneous anaplastic large cell lymphoma.
Liu HL; Hoppe RT; Kohler S; Harvell JD; Reddy S; Kim YH
J Am Acad Dermatol; 2003 Dec; 49(6):1049-58. PubMed ID: 14639383
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of Associated Lymphomas and Their Risk Factors in Patients with Lymphomatoid Papulosis: A Retrospective Single-Center Study from Turkey.
Baykal C; Kılıç Sayar S; Yazganoğlu KD; Büyükbabani N
Turk J Haematol; 2021 Feb; 38(1):49-56. PubMed ID: 33389922
[TBL] [Abstract][Full Text] [Related]
13. A variant of lymphomatoid papulosis simulating primary cutaneous aggressive epidermotropic CD8+ cytotoxic T-cell lymphoma. Description of 9 cases.
Saggini A; Gulia A; Argenyi Z; Fink-Puches R; Lissia A; Magaña M; Requena L; Simonitsch I; Cerroni L
Am J Surg Pathol; 2010 Aug; 34(8):1168-75. PubMed ID: 20661014
[TBL] [Abstract][Full Text] [Related]
14. Lymphomatoid papulosis: Treatment response and associated lymphomas in a study of 180 patients.
Wieser I; Oh CW; Talpur R; Duvic M
J Am Acad Dermatol; 2016 Jan; 74(1):59-67. PubMed ID: 26518172
[TBL] [Abstract][Full Text] [Related]
15. Long-term Follow-up of a Case of Lymphomatoid Papulosis with a Benign Course.
Balić A; Bartolić L; Ilić I; Radoš J
Acta Dermatovenerol Croat; 2018 Oct; 26(3):264-266. PubMed ID: 30390731
[TBL] [Abstract][Full Text] [Related]
16. Novel use of 308-nm excimer laser to treat a primary cutaneous CD30+ lymphoproliferative nodule.
Meisenheimer JL
J Drugs Dermatol; 2007 Apr; 6(4):440-2. PubMed ID: 17668543
[TBL] [Abstract][Full Text] [Related]
17. Expression of chemokines and chemokine receptors in cutaneous CD30+ lymphoproliferative disorders.
Yamaguchi T; Ohshima K; Karube K; Kawano R; Nakayama J; Suzumiya J; Kikuchi M
Br J Dermatol; 2006 May; 154(5):904-9. PubMed ID: 16634894
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous CD30-positive T-cell lymphoproliferative disorders-clinical and histopathologic features, differential diagnosis, and treatment.
Kempf W; Kerl K; Mitteldorf C
Semin Cutan Med Surg; 2018 Mar; 37(1):24-29. PubMed ID: 29719017
[TBL] [Abstract][Full Text] [Related]
19. Lymphomatoid papulosis and anaplastic large cell lymphomas of the skin.
Drews R; Samel A; Kadin ME
Semin Cutan Med Surg; 2000 Jun; 19(2):109-17. PubMed ID: 10892712
[TBL] [Abstract][Full Text] [Related]
20. Lymphomatoid papulosis with DUSP22-IRF4 rearrangement: A case report and literature review.
Niu N; Heberton MM; Tang Z; Aung PP; Nagarajan P; Curry JL; Prieto VG; Torres-Cabala CA; Cho WC
J Cutan Pathol; 2023 Aug; 50(8):711-716. PubMed ID: 36944579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
